Compare KraneShares Hang Seng TECH Index ETF (KTEC) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KraneShares Hang Seng TECH Index ETF vs Nuvation Bio Inc. Class A Common Stock — how do they compare? KraneShares Hang Seng TECH Index ETF trades at $11.8 (market cap $45.04M), while Nuvation Bio Inc. Class A Common Stock trades at $4.99 (market cap $1.74B). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 38.6× KraneShares Hang Seng TECH Index ETF's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold KraneShares Hang Seng TECH Index ETF for 44 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| KTEC | NUVB | |
|---|---|---|
Market Cap | $45.04M | $1.74B |
Volume | 29,043 | 9,289,619 |
Sector | Sector/Thematic | Health |
52-Week High | $18.73 | $9.54 |
52-Week Low | $11.41 | $3.41 |
Typical Hold Time | 44 Days | 1 Days |
Enterprise Value | — | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About KraneShares Hang Seng TECH Index ETF
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
